New blood-drug monitoring platform receives €10M funding
The platform will first be used to measure the concentration of beta-lactam antibiotics – used to treat or prevent bacterial infections – in a patient’s blood. (Image: Pexels/Karolina Grabowska)
The platform, which employs therapeutic drug monitoring and optical technology, could pave the way for personalised and faster care
Register for FREE to keep reading
Join 15,000+ photonics professionals staying ahead with:
- Exclusive insights, funding alerts & market trends
- Curated newsletters and digital editions
- Access to The Photonics100 list of R&D champions
- Exclusive panels & roundtables for professional development
- Technical White Papers & product updates to guide smarter decisions
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
